HomeADAP • NASDAQ
Follow
Adaptimmune Therapeutics PLC - ADR
Previous close
$1.58
Day range
$1.53 - $1.65
Year range
$0.42 - $2.05
Market cap
389.98M USD
Avg Volume
1.85M
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 231.00K | -97.91% |
Operating expense | -76.42M | 16.71% |
Net income | -47.92M | -63.82% |
Net profit margin | -20.74K | -7,720.87% |
Earnings per share | -0.24 | -33.33% |
EBITDA | -46.98M | -99.87% |
Effective tax rate | 1.35% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 146.94M | -28.18% |
Total assets | 282.62M | -14.08% |
Total liabilities | 243.10M | -1.59% |
Total equity | 39.51M | — |
Shares outstanding | 246.83M | — |
Price to book | 9.29 | — |
Return on assets | -43.03% | — |
Return on capital | -139.67% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -47.92M | -63.82% |
Cash from operations | -14.68M | -818.71% |
Cash from investing | 68.20M | 225.49% |
Cash from financing | 74.00K | -94.73% |
Net change in cash | 53.94M | 86.73% |
Free cash flow | -31.67M | -1,694.94% |
About
Founded
2008
Website
Employees
449